top of page
Advancing Innovations in Immunoengineering, Drug and Gene Delivery, Mucosal Theraputics and Cancer Therapy
Latest News
-
9/23/2026: Mucommune Awarded Contraceptive Research & Development Center from NIH to Advance its Novel, Antibody-Based Non-Hormonal Contraceptives into Clinical Trials
-
9/14/2026: Mucommune Appoints Matthijs Schoots as Vice President, Operations
-
6/10/2026: Our paper "A versatile capsule-intravaginal ring platform enables rapid and sustained release of monoclonal antibodies for non-hormonal contraception" has been published in Journal of Controlled Release
-
11/17/2025: Mucommune Awarded ARPA-H Funding to Develop Novel In Vivo CAR-T Therapy for Cancer
-
7/23/2025: UNC, Mucommune develops next-generation contraceptive antibody – Schaefer et al., Advanced Science
-
6/10/2025: Mucommune develops fast-dissolving antibody vaginal tablet for rapid, on-demand protection –
Kushiro et al., Journal of Controlled Release
bottom of page